Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease

Title:Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease

Volume: 16 Issue: 3

Author(s): F. Pandolfi, S. Frosali, L. Petruzziello, E.E. Newton and G. Costamagna

Affiliation:

Keywords: Diverticular disease, rifaximin, mucosal immunity, TLR2, TLR4, T-lymphocytes.

Abstract: We review our experience on Rifaximin in uncomplicated diverticular disease. Our data show that a 2 week treatment induces modifications in the immune system: local mucosal lymphocytes with TLR-4 were increased. In the peripheral blood CD103 cells, which increased before treatment, returned to normal values after Rifaximin.

Cite this article as:

Pandolfi F., Frosali S., Petruzziello L., Newton E.E. and Costamagna G., Central and Mucosal Immunities are Modified by Non Adsorbable Antibiotic Treatment in Uncomplicated Diverticular Disease, Mini-Reviews in Medicinal Chemistry 2016; 16 (3) . https://dx.doi.org/10.2174/1389557515666150722104035